{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:06:17Z","timestamp":1785240377365,"version":"3.55.0"},"reference-count":57,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objective: Vitamin K (VK) comprises a family of quinone compounds with potential involvement in cell death-related pathways through their redox properties. However, consistent findings have not been obtained regarding the clinical significance of VK in breast cancer (BC). Thus, we used the FDA Adverse Event Reporting System (FAERS) to examine the co-reporting patterns of BC-related reporting terms among VK-related reports. Methods: FAERS reports from 2004 Q1 to 2024 Q3 were analyzed using narrow-scope Preferred Terms from two BC-related Standardized MedDRA Queries. Reporting odds ratios (RORs), proportional reporting ratios (PRRs), Fisher\u2019s exact tests, and expected co-report counts under independence were calculated for VK overall and individual homologs, followed by exploratory comparisons with other quinone-containing compounds. An INDI-based sensitivity analysis excluded reports with BC-related indication terms. Results: Among 32,156 VK-related reports, 136 were BC-related. VK overall showed significantly lower reporting disproportionality (ROR, 0.486; 95% confidence interval [CI], 0.411\u20130.575). The predefined criteria for lower reporting disproportionality were also met for phytomenadione (VK1), menatetrenone (MK-4), the integrated VK2 category, and menadione (VK3). For VK3, 2 co-reports were observed compared with 13.59 expected (ROR, 0.183; 95% CI, 0.053\u20130.631). In the INDI-based sensitivity analysis, the lower reporting pattern remained for VK overall and VK1, was retained but borderline for the integrated VK2 category, and was not retained for MK-4 or VK3. Conclusions: In FAERS, BC-related terms were infrequently co-reported with VK-related reports (ROR &lt; 1), with this pattern being partially retained in the INDI-based sensitivity analysis. This reporting pattern does not indicate reduced incidence, a protective or antitumor effect, or any causal relationship. However, it may reflect the indication structure of the comparator reporting population and other sources of reporting biases. These descriptive observations are presented solely to generate hypotheses for future mechanistic research and analytical epidemiological studies with more rigorous confounding control.<\/jats:p>","DOI":"10.3390\/ph19081181","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:45:26Z","timestamp":1785239126000},"page":"1181","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disproportionality Analysis of Breast Cancer-Related Reports Across Vitamin K Homologs in the FDA Adverse Event Reporting System"],"prefix":"10.3390","volume":"19","author":[{"given":"Shinsuke","family":"Miyazawa","sequence":"first","affiliation":[{"name":"Department of Community Health Care and Sciences, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi 204-8588, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-991X","authenticated-orcid":false,"given":"Yoshihiro","family":"Uesawa","sequence":"additional","affiliation":[{"name":"Department of Medical Molecular Informatics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi 204-8588, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH08-03-0147","article-title":"Metabolism and cell biology of vitamin K","volume":"100","author":"Shearer","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.3402\/fnr.v56i0.5329","article-title":"Vitamin K: The effect on health beyond coagulation: An overview","volume":"56","author":"Vermeer","year":"2012","journal-title":"Food Nutr. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1538-7836.2005.01419.x","article-title":"The vitamin K cycle","volume":"3","author":"Stafford","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","article-title":"A non-canonical vitamin K cycle is a potent ferroptosis suppressor","volume":"608","author":"Mishima","year":"2022","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.redox.2018.03.013","article-title":"Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect","volume":"16","author":"Ivanova","year":"2018","journal-title":"Redox Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40485","DOI":"10.1074\/jbc.M607704200","article-title":"Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells","volume":"281","author":"Criddle","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ka\u017amierczak-Bara\u0144ska, J., and Karwowski, B.T. (2022). Vitamin K contribution to DNA damage-advantage or disadvantage? A human health response. Nutrients, 14.","DOI":"10.3390\/nu14204219"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.leu.2400667","article-title":"Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid","volume":"11","author":"Yaguchi","year":"1997","journal-title":"Leukemia"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tauchi, T., Moriya, S., Okabe, S., Kazama, H., Miyazawa, K., and Takano, N. (2024). Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0307662"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12282-019-01012-y","article-title":"Vitamin K2 induces non-apoptotic cell death along with autophagosome formation in breast cancer cell lines","volume":"27","author":"Miyazawa","year":"2020","journal-title":"Breast Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3945\/ajcn.2009.28691","article-title":"Dietary vitamin K intake in relation to cancer incidence and mortality: Results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg)","volume":"91","author":"Nimptsch","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1016\/j.clnu.2020.11.009","article-title":"Vitamin K intake and breast cancer incidence and death: Results from a prospective cohort study","volume":"40","author":"Wang","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Behrad Nasab, M., Afsharfar, M., Ahmadzadeh, M., Vahid, F., Gholamalizadeh, M., Abbastorki, S., Davoodi, S.H., Majidi, N., Akbari, M.E., and Doaei, S. (2022). Comparison of the index of nutritional quality in breast cancer patients with healthy women. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.811827"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/0113894501290296240327081624","article-title":"Drug repurposing using FDA adverse event reporting system (FAERS) database","volume":"25","author":"Morris","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1111\/bcp.14868","article-title":"Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections","volume":"87","author":"Bulin","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/ijms.13834","article-title":"Inverse association between sodium channel-blocking antiepileptic drug use and cancer: Data mining of spontaneous reporting and claims databases","volume":"13","author":"Takada","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hosomi, K., Fujimoto, M., Ushio, K., Mao, L., Kato, J., and Takada, M. (2018). An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204648"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17562864241241383","DOI":"10.1177\/17562864241241383","article-title":"Exploring the association between weight loss-inducing medications and multiple sclerosis: Insights from the FDA adverse event reporting system database","volume":"17","author":"Shirani","year":"2024","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107113","DOI":"10.1016\/j.msard.2026.107113","article-title":"Bile acids as candidate therapies for multiple sclerosis: Inverse signal analysis using the FDA adverse event reporting system and preclinical validation","volume":"109","author":"Asada","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00280-009-1016-7","article-title":"The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway","volume":"65","author":"Akiyoshi","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3892\/ijo.2015.3113","article-title":"Novel therapy for locally advanced triple-negative breast cancer","volume":"47","author":"Yamada","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3892\/ijo.2015.3033","article-title":"Inhibitory effect of vitamin K1 on growth and polyamine biosynthesis of human gastric and colon carcinoma cell lines","volume":"47","author":"Linsalata","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10654-021-00806-9","article-title":"Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort","volume":"36","author":"Palmer","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cheung, A.M., Tile, L., Lee, Y., Tomlinson, G., Hawker, G., Scher, J., Hu, H., Vieth, R., Thompson, L., and Jamal, S. (2008). Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): A randomized controlled trial. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050247"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.18632\/oncotarget.26765","article-title":"Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells","volume":"10","author":"Beaudin","year":"2019","journal-title":"Oncotarget"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature09464","article-title":"Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme","volume":"468","author":"Nakagawa","year":"2010","journal-title":"Nature"},{"key":"ref_27","first-page":"1779","article-title":"In vivo metabolism of vitamin K: In relation to the conversion of vitamin K1 to MK-4","volume":"19","author":"Okano","year":"2009","journal-title":"Clin. Calcium"},{"key":"ref_28","first-page":"627","article-title":"Apoptosis induction of vitamin K2 in lung carcinoma cell lines: The possibility of vitamin K2 therapy for lung cancer","volume":"23","author":"Yoshida","year":"2003","journal-title":"Int. J. Oncol."},{"key":"ref_29","first-page":"235","article-title":"Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines","volume":"17","author":"Tokita","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00432-007-0349-z","article-title":"Induction of apoptosis in PA-1 ovarian cancer cells by vitamin K2 is associated with an increase in the level of TR3\/Nur77 and its accumulation in mitochondria and nuclei","volume":"134","author":"Fujisawa","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Duan, F., Yu, Y., Guan, R., Xu, Z., Liang, H., and Hong, L. (2016). Vitamin K2 induces mitochondria-related apoptosis in human bladder cancer cells via ROS and JNK\/p38 MAPK signal pathways. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161886"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/mol.112.082602","article-title":"Vitamin K2 covalently binds to Bak and induces Bak-mediated apoptosis","volume":"83","author":"Karasawa","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4161\/auto.5941","article-title":"Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells","volume":"4","author":"Yokoyama","year":"2008","journal-title":"Autophagy"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.leu.2402155","article-title":"Apoptosis\/differentiation-inducing effects of vitamin K2 on HL-60 cells: Dichotomous nature of vitamin K2 in leukemia cells","volume":"15","author":"Miyazawa","year":"2001","journal-title":"Leukemia"},{"key":"ref_35","first-page":"159","article-title":"Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-\u03baB activation","volume":"25","author":"Zhang","year":"2011","journal-title":"Oncol. Rep."},{"key":"ref_36","first-page":"8926","article-title":"Research progress on the anticancer effects of vitamin K2 (Review)","volume":"15","author":"Xv","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.freeradbiomed.2010.09.021","article-title":"Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis","volume":"49","author":"Loor","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12419","DOI":"10.1016\/S0021-9258(18)33730-X","article-title":"The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes: A study of the implications of oxidative stress in intact cells","volume":"257","author":"Thor","year":"1982","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2141.2002.03418.x","article-title":"Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells","volume":"117","author":"Liu","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2141.2001.03216.x","article-title":"Generation of reactive oxygen species is not involved in idarubicin-induced apoptosis in human leukaemic cells","volume":"115","author":"Liu","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Han, W., Sun, J., Feng, L., Wang, K., Li, D., Pan, Q., Chen, Y., Jin, W., Wang, X., and Pan, H. (2011). Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028491"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yexcr.2014.05.021","article-title":"Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells","volume":"326","author":"Ristic","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1038\/s41467-024-52523-y","article-title":"Cancer cell stiffening via CoQ10 and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer","volume":"15","author":"Tosi","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101882","DOI":"10.1016\/j.jsps.2023.101882","article-title":"Protective effect of coenzyme Q10 against doxorubicin-induced cardiotoxicity: Scoping review article","volume":"32","year":"2024","journal-title":"Saudi Pharm. J."},{"key":"ref_47","unstructured":"(2025, June 13). FDA, Available online: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-adverse-event-reporting-system-faers-database."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Watanabe, A., and Uesawa, Y. (2025). Steroid-induced thrombosis: A comprehensive analysis using the FAERS database. Pharmaceuticals, 18.","DOI":"10.20944\/preprints202507.0253.v1"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Yamada, S., and Uesawa, Y. (2025). Exploring adverse event associations of predicted PXR agonists using the FAERS database. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202507.0150.v1"},{"key":"ref_50","unstructured":"Swain, M. (2025, June 13). Available online: https:\/\/github.com\/mcs07\/pubchempy."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_52","unstructured":"(2025, September 02). Molecular Operating Environment. Available online: https:\/\/www.chemcomp.com\/en\/Products.htm."},{"key":"ref_53","unstructured":"(2025, September 02). Introductory Guide for Standardised MedDRA Queries (SMQs) Version 27.1. Available online: https:\/\/www.jmo.pmrj.jp\/download\/2361."},{"key":"ref_54","unstructured":"(2025, September 02). Introductory Guide MedDRA Version 27.1. Available online: https:\/\/www.jmo.pmrj.jp\/download\/2360."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance of the logarithm of a ratio of frequencies","volume":"20","author":"Haldane","year":"1956","journal-title":"Ann. Hum. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/biomet\/43.3-4.461","article-title":"On estimating binomial response relations","volume":"43","author":"Anscombe","year":"1956","journal-title":"Biometrika"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/1740774513485311","article-title":"Summarizing the incidence of adverse events using volcano plots and time intervals","volume":"10","author":"Zink","year":"2013","journal-title":"Clin. Trials"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1181\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:54:25Z","timestamp":1785239665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ph19081181"],"URL":"https:\/\/doi.org\/10.3390\/ph19081181","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}